Piperaquine phosphate is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications. Its therapeutic use is listed as anti-infectives. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Quinoline, 4, 4′-(1, 3-propanediyldi-4, 1-piperazinediyl)bis(7-chloro-, phosphate and piperaquine tetraphosphate tetrahydrate. Its PubChem CID is 174478.
Piperaquine phosphate
| CAS No | 85547-56-4 |
|---|---|
| Molecular Formula | C29H35Cl2N6O4P |
| Molecular Weight | 633.5 g/mol |
| Synonyms | 7-chloro-4-[4-[3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl]piperazin-1-yl]quinoline;phosphoric acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Piperaquine phosphate is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications. Its therapeutic use is listed as anti-infectives.
The listed CAS number is 85547-56-4.
The listed molecular formula is C29H35Cl2N6O4P.
The listed molecular weight is 633.5 g/mol.
7-chloro-4-[4-[3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl]piperazin-1-yl]quinoline;phosphoric acid.
The source lists Quinoline, 4, 4'-(1, 3-propanediyldi-4, 1-piperazinediyl)bis(7-chloro-, phosphate and piperaquine tetraphosphate tetrahydrate.